Market Cap
$237.65 M
-$29.42 M-11.02%
7 min ago
Summary
- As of February 7, 2025, SGMO market capitalization is $237.65 million, with a fall of -$29.42 million (-11.02%) during the most recent trading day.
- Over the past year, SGMO market cap has increased by +$146.66 million (+161.18%).
- SGMO market cap is now -90.76% below its all-time high of $2.57 billion.
Performance
SGMO Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
SGMO Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | -11.0% | -11.0% | +0.0% | -11.5% |
| 1 m1 month | -18.6% | -18.6% | - | -19.4% |
| 3 m3 months | -59.8% | -59.8% | - | -60.9% |
| 6 m6 months | +34.3% | +34.0% | - | +26.9% |
| ytdytd | +11.7% | +11.7% | - | +12.3% |
| 1 y1 year | +161.2% | +123.0% | +17.1% | +169.6% |
| 5 y5 years | -72.8% | -84.9% | +79.9% | -73.0% |
SGMO Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.6% | $217 M | +9.5% | |
| 3 m | 3-month | $626 M | -62.0% | $193 M | +22.9% |
| 6 m | 6-month | $626 M | -62.0% | $150 M | +58.0% |
| 1 y | 1-year | $626 M | -62.0% | $68 M | +251.2% |
| 3 y | 3-year | $1.00 B | -76.2% | $57 M | +318.8% |
| 5 y | 5-year | $2.57 B | -90.8% | $57 M | +318.8% |
| alltime | all time | $2.57 B | -90.8% | $32 M | +642.8% |
Sangamo Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2025 | $237.65 M(+11.7%) |
| 2024 | $212.82 M(+109.6%) |
| 2023 | $101.54 M(-81.0%) |
| 2022 | $533.74 M(-51.2%) |
| 2021 | $1.09 B(-50.6%) |
| 2020 | $2.22 B(+128.5%) |
| 2019 | $970.69 M(-17.3%) |
| 2018 | $1.17 B(-16.4%) |
| 2017 | $1.40 B(+549.4%) |
| 2016 | $216.16 M(-66.3%) |
| 2015 | $642.34 M(-38.9%) |
| 2014 | $1.05 B(+21.5%) |
| 2013 | $864.57 M(+171.1%) |
| Date | Value |
|---|---|
| 2012 | $318.88 M(+113.6%) |
| 2011 | $149.26 M(-50.5%) |
| 2010 | $301.31 M(+13.1%) |
| 2009 | $266.37 M(+86.8%) |
| 2008 | $142.61 M(-72.8%) |
| 2007 | $524.91 M(+126.9%) |
| 2006 | $231.30 M(+87.7%) |
| 2005 | $123.20 M(-18.7%) |
| 2004 | $151.63 M(+11.1%) |
| 2003 | $136.50 M(+83.3%) |
| 2002 | $74.47 M(-67.4%) |
| 2001 | $228.66 M(-47.1%) |
| 2000 | $431.87 M |
FAQ
- What is Sangamo Therapeutics market capitalization?
- What is the all time high market cap for Sangamo Therapeutics?
- What is SGMO market capitalization year-to-date change?
- What is Sangamo Therapeutics market cap year-on-year change?
What is Sangamo Therapeutics market capitalization?
The current market cap of SGMO is $237.65 M
What is the all time high market cap for Sangamo Therapeutics?
Sangamo Therapeutics all-time high market capitalization is $2.57 B
What is SGMO market capitalization year-to-date change?
Sangamo Therapeutics market capitalization has changed by +$24.83 M (+11.67%) since the beginning of the year
What is Sangamo Therapeutics market cap year-on-year change?
Over the past year, SGMO market capitalization has changed by +$146.66 M (+161.18%)